These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7687478)

  • 21. Can cytotoxic activity of anthracyclines be related to DNA damage?
    Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H
    Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
    Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
    Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the DNA structure of peripheral blood leukocytes, proliferating lymphoid and tumor cells according to the rate of alkaline denaturation of DNA lysates].
    Moskaleva EIu; Diachenko LV; Mironova SB; Fedorov NA
    Gematol Transfuziol; 1989 Apr; 34(4):40-2. PubMed ID: 2744380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antileukemic activity of phenylalanine methyl ester (PME): a lysosomotropic peptide methyl ester.
    Rosenfeld CS
    Stem Cells; 1994 Mar; 12(2):198-204. PubMed ID: 8199562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of sequence-specific antitumor alkylating agent DNA damage from cells treated in culture and from a patient.
    Bubley GJ; Ogata GK; Dupuis NP; Teicher BA
    Cancer Res; 1994 Dec; 54(24):6325-9. PubMed ID: 7987822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in postimplantation rat embryos.
    Little SA; Mirkes PE
    Cancer Res; 1987 Oct; 47(20):5421-6. PubMed ID: 3477317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DNA breaks in the leukocytes and tumor cells as an indicator of therapeutic activity of cytostatics].
    Skotnikova OI; Oan' NF; Borisov BN; Sevast'ianova MG; Fedorov NA
    Probl Gematol Pereliv Krovi; 1980 May; 25(5):15-9. PubMed ID: 6931363
    [No Abstract]   [Full Text] [Related]  

  • 29. DNA synthesis inhibition of nitroxide radicals on leukemia cells.
    Liu LS; Zheng RL; Swartz HM; Zhang ZY; Wei LL
    Sci China B; 1991 Sep; 34(9):1063-9. PubMed ID: 1821128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH
    Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells.
    Erikson JM; Tweedie DJ; Ducore JM; Prough RA
    Cancer Res; 1989 Jan; 49(1):127-33. PubMed ID: 2908840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of action of antileukemic agents in leukemia chemotherapy].
    Nakamura T
    Rinsho Ketsueki; 1996 May; 37(5):380-91. PubMed ID: 8691581
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
    Domenech J; Desbois I; Linassier C; Gihana E; Chenault S; Brémond JL; Colombat P; Lamagnère JP; Binet C
    Bone Marrow Transplant; 1993 Jun; 11(6):425-31. PubMed ID: 8334422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.
    Gewirtz DA; Ellis AL; Randolph JK; Yanovich S; Swerdlow PS; Povirk LF; Yalowich JC
    Cancer Commun; 1989; 1(3):175-80. PubMed ID: 2561738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro evaluation of the alkylating agent carmethizole.
    Elliott WL; Fry DW; Anderson WK; Nelson JM; Hook KE; Hawkins PA; Leopold WR
    Cancer Res; 1991 Sep; 51(17):4581-7. PubMed ID: 1873802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In search of a key.
    Roberts D
    Natl Cancer Inst Monogr; 1971 Dec; 34():118-30. PubMed ID: 4946577
    [No Abstract]   [Full Text] [Related]  

  • 37. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA strand breaks in cells with DNA repair deficiency after halothane exposure in vitro.
    Reitz M; Lanz E
    Arzneimittelforschung; 1993 Apr; 43(4):418-20. PubMed ID: 8494571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docosahexaenoic acid ethyl ester and its ultraviolet degradation products showed DNA-breaking activity in vitro and cytotoxic effects on the HSC-4 cell line.
    Liu W; Nishio H; Mio T; Sumino K
    Kobe J Med Sci; 1995 Dec; 41(6):235-45. PubMed ID: 8869009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In situ nick translation for detection of DNA damages in glioma cells].
    Taki T; Arita N; Hayakawa T; Yamamoto H; Izumoto S; Oonisi T; Mogami H
    No To Shinkei; 1989 Nov; 41(11):1065-70. PubMed ID: 2620007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.